封面
市场调查报告书
商品编码
1565025

全球血液透析机市场

Hemodialysis

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球血液透析机市场将达1,306亿美元

全球血液透析机市场预估2023年为951亿美元,预估至2030年将达1,306亿美元,2023年至2030年复合年增长率为4.6%。血液透析机服务是血液透析机报告中分析的细分市场之一,预计复合年增长率为 4.8%,到分析期结束时将达到 801 亿美元。分析期间,血液透析机药品领域的复合年增长率预计为 3.9%。

美国市场预估251亿美元,中国预期复合年增长率7.2%

预计 2023 年美国血液透析机市场规模将达 251 亿美元。中国作为世界第二大经济体,预计2030年市场规模将达287亿美元,2023-2030年分析期间复合年增长率为7.2%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 2.8% 和 3.8%。在欧洲,德国的复合年增长率预计为 3.3%。

全球血液透析机市场-主要趋势与驱动因素总结

血液透析机是慢性肾臟病病患者的生命线吗?

血液透析机对于肾衰竭和慢性肾臟病(CKD) 患者来说是一种挽救生命的治疗方法,但是什么让血液透析机如此重要呢?血液透析机是一种当肾臟不再能够发挥其功能时从血液中过滤废物、盐和多余水分的医疗过程。血液透析机可以人工取代肾功能,帮助患者维持液体和电解质平衡、清除毒素并控制血压。如果不血液透析机,末期肾病患者的血液中就会积聚毒素,并面临危及生命的併发症。

这种治疗对于 CKD 患者尤其重要,它为等待肾臟移植的患者提供了重要的生存手段,或作为不适合移植的患者的长期治疗手段。血液透析机通常需要每週在透析中心或家用中进行多次治疗,具体取决于透析的类型。每次透析持续几个小时,血液在被泵回体内之前会透过透析设备过滤。随着全球肾臟疾病盛行率持续上升,特别是糖尿病和高血压的盛行率,血液透析机的需求不断增加,并已成为现代医学的重要组成部分。

科技如何改善血液透析机治疗?

医疗技术的进步极大地提高了血液透析机的有效性、舒适度和可及性,将其从一种困难的治疗转变为更易于管理且对患者友好的治疗。最引人注目的技术创新之一是家庭透析治疗设备(HHD)的开发,它允许患者在舒适的家用中进行透析。这种可携式、紧凑的设备可以增加透析频率和安排灵活性,从而改善健康和生活品质。居家血液透析机减少了患者每週多次前往透析中心的需要,从而可以在不干扰日常生活的情况下进行治疗。

此外,透析设备的技术改进使得透析过程更有效率且对身体的负担更小。现代透析设备配备了更好的感测器、先进的软体和自动化系统,可即时密切监测血流量、过滤率和液体平衡。这些创新使每次透析疗程都能根据患者的特定需求进行最佳化,减少低血压和液体超负荷等併发症。此外,生物相容性更强的透析膜(例如合成聚合物透析膜)的开发提高了透析设备的过滤能力,并最大限度地减少发炎和凝血,使治疗更安全、更有效。

另一个重要的进步是将穿戴式科技和远端医疗纳入护理中。远端监控系统现在允许医疗保健提供者即时追踪患者的生命体征和治疗资料,即使家用进行透析也是如此。这种连接可以及早发现潜在问题,例如感染疾病或访问站点问题,从而可以及时干预,减少住院治疗并改善患者治疗效果。此外,血管通路装置的进步,例如更耐用和侵入性较小的动静脉瘻管的开发,正在延长通路部位的寿命,减少併发症,并减少重复手术的需要。这些技术进步使血液透析机更加高效、安全,并且更容易为世界各地的患者所接受。

为什么肾衰竭患者需要进行血液透析机?

血液透析机对于肾衰竭患者至关重要,因为当肾臟不再能够执行这些重要功能时,血液透析是清除体内废物和多余液体的唯一有效治疗方法。当肾臟衰竭时,毒素、过量的钾和液体会在血液中积聚,导致严重的併发症,例如心血管问题、肺部液体储存和危险的电解质失衡。如果不进行透析,这种情况会迅速导致器官衰竭和死亡。血液透析机透过模仿健康肾臟的过滤过程来管理这些风险,使患者能够维持正常的身体功能。

除了维持生命的作用外,血液透析机还使患者能够过着相对积极的生活。透过控制体内废物和水分含量,这种治疗可以减轻晚期肾臟病患者常见的疲劳、肿胀和呼吸急促等症状。儘管透析不能完全治癒肾衰竭,但它可以显着改善生活品质并帮助患者长期控制病情。对许多患者来说,血液透析机是肾臟移植的桥樑,而对于不适合移植的患者来说,这是一种终身治疗。

血液透析机在管理与肾衰竭相关的其他健康併发症(例如贫血和骨骼疾病)方面也发挥着重要作用。在透析过程中,通常会施用药物来改善这些症状,使其成为治疗肾衰竭复杂症状的全面治疗方法。对于末期肾功能衰竭(ESRD) 患者来说,血液透析机不仅是一种治疗方法,而且是维持健康和预防潜在致命併发症的必要条件。肾臟疾病的盛行率在全球范围内不断增加,血液透析机仍然是数百万人的重要治疗选择,特别是在糖尿病和高血压盛行率较高的人群中。

推动血液透析机市场成长的因素有哪些?

血液透析机市场的成长受到几个关键因素的推动,包括慢性肾臟病(CKD)盛行率的上升、透析设备的技术进步以及全球人口老化。最大的影响因素之一是 CKD 盛行率不断上升,特别是作为肾臟疾病主要原因的糖尿病和高血压等疾病在全球范围内持续增加。随着全球肾臟疾病负担的增加,对包括血液透析机的透析服务的需求正在迅速增加。在肥胖、METABOLIC INC.症候群和心血管疾病发生率较高的地区,对方便的透析治疗的需求日益增长。

透析设备和治疗方法的技术进步也促进了市场的成长。居家透析设备(HHD)、更有效率的透析膜和改良的血管通路设备等创新使治疗变得更加患者友善和方便。特别是,越来越多的患者和医疗保健提供者认识到家庭透析治疗与传统中心透析相比的好处:灵活性、改善健康状况和提高生活质量,并且越来越受欢迎。可携式透析设备和穿戴式监测技术的日益普及也刺激了血液透析机在已开发市场和新兴市场的采用。

人口老化也是推动血液透析机市场成长的主要因素。随着世界人口老化,肾臟疾病的发生率不断增加,特别是在 60 岁以上的人群中。由于与老龄化相关的肾功能下降以及糖尿病和高血压等合併症的盛行率较高,老年人更容易患 CKD。这些人口趋势增加了对血液透析机服务和基础设施的需求,以满足越来越多需要长期肾臟护理的患者的需求。

最后,新兴市场医疗基础设施的改善和透析中心的扩张正在促进血液透析机市场的成长。政府和私人医疗保健提供者正在投资扩大透析服务,以满足日益增长的治疗需求,特别是在传统上获得肾臟治疗机会有限的地区。此次扩张将改善农村和服务欠缺地区的透析服务,推动市场成长,并使更多患者能够获得挽救生命的血液透析机治疗。随着世界各地医疗保健系统的不断发展,对有效且易于使用的血液透析机解决方案的需求预计将增长并巩固其作为肾臟疾病管理关键组成部分的作用。

受访企业举例(共52家)

  • Argon Medical Devices, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Baxter International, Inc.
  • DaVita Healthcare Partners, Inc.
  • Fresenius Medical Care AG & Co. KgaA
  • Kawasumi Laboratories, Inc.
  • Medical Components, Inc.
  • Merit Medical Systems, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Teleflex, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP12339

Global Hemodialysis Market to Reach US$130.6 Billion by 2030

The global market for Hemodialysis estimated at US$95.1 Billion in the year 2023, is expected to reach US$130.6 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Hemodialysis Services, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$80.1 Billion by the end of the analysis period. Growth in the Hemodialysis Drugs segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.1 Billion While China is Forecast to Grow at 7.2% CAGR

The Hemodialysis market in the U.S. is estimated at US$25.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$28.7 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Hemodialysis Market - Key Trends and Drivers Summarized

Is Hemodialysis the Lifeline for Patients with Chronic Kidney Disease?

Hemodialysis is a life-saving treatment for individuals with kidney failure or chronic kidney disease (CKD), but what makes it so essential? Hemodialysis is a medical process that filters waste, salts, and excess fluids from the blood when the kidneys can no longer perform this function. It acts as an artificial replacement for kidney function, helping patients maintain a balance of fluids and electrolytes, remove toxins, and manage blood pressure. Without hemodialysis, individuals with end-stage kidney disease would face life-threatening complications from toxin buildup in their bloodstream.

This treatment is particularly important for patients with CKD, as it provides a critical means of survival while they await a kidney transplant or as long-term management for those who are not eligible for transplantation. Hemodialysis typically requires patients to undergo treatments multiple times a week, either in a dialysis center or at home, depending on the type of dialysis prescribed. Each session can last several hours, during which blood is filtered through a dialysis machine before being returned to the body. As the incidence of kidney disease continues to rise globally, particularly with increasing rates of diabetes and hypertension, the demand for hemodialysis has grown, making it a crucial part of modern healthcare.

How Has Technology Enhanced Hemodialysis Treatment?

Advancements in medical technology have significantly improved the effectiveness, comfort, and accessibility of hemodialysis, transforming it from a challenging procedure to a more manageable and patient-friendly treatment. One of the most notable innovations is the development of home hemodialysis (HHD) machines, which allow patients to perform dialysis in the comfort of their own homes. These portable, compact devices enable more frequent dialysis sessions with greater flexibility in scheduling, leading to better health outcomes and improved quality of life. Home hemodialysis reduces the need for patients to travel to dialysis centers multiple times a week, making the treatment less disruptive to daily life.

Technological improvements in dialysis machines have also made the process more efficient and less taxing on the body. Modern machines feature better sensors, advanced software, and automated systems that closely monitor blood flow, filtration rates, and fluid balance in real time. These innovations ensure that each dialysis session is optimized for the patient’s specific needs, reducing complications such as hypotension or fluid overload. Furthermore, developments in biocompatible dialysis membranes—such as those made from synthetic polymers—have enhanced the filtering capabilities of dialysis machines while minimizing inflammation and clotting, making treatments safer and more effective.

Another key advancement is the integration of wearable technologies and telemedicine into hemodialysis care. Remote monitoring systems now allow healthcare providers to track a patient’s vitals and treatment data in real-time, even when dialysis is performed at home. This connectivity enables early detection of potential issues, such as infections or access site problems, and allows for timely interventions, reducing hospital admissions and improving patient outcomes. In addition, advancements in vascular access devices, such as the creation of more durable and less invasive arteriovenous (AV) fistulas, have extended the lifespan of access sites, reducing complications and the need for repeated surgeries. These technological enhancements are making hemodialysis more efficient, safer, and accessible for patients worldwide.

Why Is Hemodialysis Essential for Patients with Kidney Failure?

Hemodialysis is essential for patients with kidney failure because it serves as the only effective treatment option for removing waste products and excess fluid from the body when the kidneys can no longer perform these vital functions. In the absence of functioning kidneys, the buildup of toxins, excess potassium, and fluids in the bloodstream can lead to severe complications, including cardiovascular issues, fluid retention in the lungs, and dangerous electrolyte imbalances. Without dialysis, these conditions would rapidly lead to organ failure and death. Hemodialysis helps manage these risks by mimicking the filtration process of healthy kidneys, allowing patients to maintain a semblance of normal bodily function.

In addition to its life-sustaining role, hemodialysis offers patients the ability to lead relatively active lives. By controlling waste and fluid levels in the body, the treatment reduces symptoms like fatigue, swelling, and shortness of breath, which are common in patients with advanced kidney disease. While dialysis does not cure kidney failure, it significantly improves quality of life and enables patients to manage their condition over the long term. For many, hemodialysis is a bridge to kidney transplantation, while for others who are not candidates for transplant, it becomes a lifelong treatment.

Hemodialysis also plays a vital role in managing other health complications related to kidney failure, such as anemia and bone disease. During dialysis sessions, patients often receive medications that help regulate these conditions, making the treatment a comprehensive approach to managing the complexities of kidney failure. For those who suffer from end-stage renal disease (ESRD), hemodialysis is not only a treatment but a necessity for maintaining health and preventing the progression of potentially fatal complications. As the prevalence of kidney disease increases globally, particularly in populations with high rates of diabetes and hypertension, hemodialysis remains a critical treatment option for millions of people.

What Factors Are Driving the Growth of the Hemodialysis Market?

The growth of the hemodialysis market is driven by several key factors, including the rising incidence of chronic kidney disease (CKD), technological advancements in dialysis equipment, and an aging global population. One of the most significant drivers is the increasing prevalence of CKD, particularly as conditions like diabetes and hypertension—two leading causes of kidney disease—continue to rise worldwide. With the global burden of kidney disease growing, the demand for dialysis services, including hemodialysis, is expanding rapidly. In regions with high rates of obesity, metabolic syndrome, and cardiovascular disease, the need for accessible dialysis treatments is becoming more urgent.

Technological advancements in dialysis machines and treatment methods are also contributing to market growth. Innovations such as home hemodialysis (HHD) machines, more efficient dialysis membranes, and improved vascular access devices are making treatments more patient-friendly and accessible. Home hemodialysis, in particular, is gaining traction as more patients and healthcare providers recognize the benefits of flexibility, improved health outcomes, and better quality of life compared to traditional in-center dialysis. The increasing availability of portable dialysis devices and wearable monitoring technologies is further fueling the adoption of hemodialysis in both developed and developing markets.

An aging population is another major factor driving the growth of the hemodialysis market. As the global population ages, the incidence of kidney disease increases, particularly among individuals over the age of 60. Older adults are more likely to develop CKD due to age-related declines in kidney function and the higher prevalence of comorbidities such as diabetes and hypertension. This demographic trend is increasing the demand for hemodialysis services and infrastructure to accommodate the growing number of patients requiring long-term kidney care.

Lastly, improved healthcare infrastructure and the expansion of dialysis centers in emerging markets are contributing to the growth of the hemodialysis market. Governments and private healthcare providers are investing in the expansion of dialysis services to meet the rising demand for treatment, particularly in regions where access to kidney care has historically been limited. This expansion is improving access to dialysis in rural and underserved areas, driving market growth and ensuring that more patients can receive life-saving hemodialysis treatments. As healthcare systems around the world continue to evolve, the demand for effective, accessible hemodialysis solutions is expected to grow, solidifying its role as a critical component of kidney disease management.

Select Competitors (Total 52 Featured) -

  • Argon Medical Devices, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Baxter International, Inc.
  • DaVita Healthcare Partners, Inc.
  • Fresenius Medical Care AG & Co. KgaA
  • Kawasumi Laboratories, Inc.
  • Medical Components, Inc.
  • Merit Medical Systems, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Teleflex, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Hemodialysis - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Kidney Disease (CKD) Propels Demand for Hemodialysis
    • Growth in Aging Population Expands Addressable Market for Hemodialysis Services
    • Technological Advancements in Hemodialysis Machines Spur Innovation and Adoption
    • Increasing Focus on Home-based Hemodialysis Expands Market Opportunities
    • Expansion of Dialysis Centers in Emerging Markets Strengthens Business Case for Hemodialysis
    • Growth in Demand for Portable Hemodialysis Devices Sets the Stage for Market Expansion
    • Role of Hemodialysis in Supporting Long-term Management of End-stage Renal Disease (ESRD)
    • Increasing Adoption of Wearable Dialysis Devices Expands Market Potential
    • Role of Artificial Intelligence in Enhancing Hemodialysis Efficiency and Outcomes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hemodialysis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Consumables & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Consumables & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Consumables & Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Dialysis Centers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Dialysis Centers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Dialysis Centers & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • CHINA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Hemodialysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hemodialysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • INDIA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Hemodialysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Hemodialysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030

IV. COMPETITION